tiprankstipranks
Trending News
More News >
Alaunos Therapeutics (TCRT)
NASDAQ:TCRT
US Market

Alaunos Therapeutics (TCRT) Ratios

Compare
695 Followers

Alaunos Therapeutics Ratios

TCRT's free cash flow for Q3 2025 was $0.00. For the 2025 fiscal year, TCRT's free cash flow was decreased by $ and operating cash flow was $0.00. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
2.92 4.22 2.23 4.91 7.11
Quick Ratio
2.92 4.22 1.65 4.91 7.11
Cash Ratio
2.10 3.10 1.62 4.74 6.26
Solvency Ratio
-4.37 -16.78 -1.32 -2.02 -3.48
Operating Cash Flow Ratio
-3.16 -15.41 -1.21 -3.83 -3.10
Short-Term Operating Cash Flow Coverage
0.00 0.00 -1.69 -7.15 -69.61
Net Current Asset Value
$ 1.76M$ 6.30M$ 27.42M$ 42.02M$ 108.23M
Leverage Ratios
Debt-to-Assets Ratio
0.00 0.00 0.30 0.31 0.03
Debt-to-Equity Ratio
0.00 0.00 0.51 0.51 0.04
Debt-to-Capital Ratio
0.00 0.00 0.34 0.34 0.04
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.22 0.00
Financial Leverage Ratio
1.33 1.31 1.68 1.63 1.18
Debt Service Coverage Ratio
0.00 -16.09 -1.55 -7.48 -94.90
Interest Coverage Ratio
0.00 -17.84 -11.13 -65.61 0.00
Debt to Market Cap
0.00 0.00 0.12 0.11 <0.01
Interest Debt Per Share
0.00 1.20 15.66 21.37 3.44
Net Debt to EBITDA
0.48 0.20 0.61 0.62 1.40
Profitability Margins
Gross Profit Margin
-2983.33%-95960.00%5.58%-85.93%0.00%
EBIT Margin
-47566.67%-664380.00%-1183.30%-19487.94%0.00%
EBITDA Margin
-67350.00%-618080.00%-1088.88%-18837.19%0.00%
Operating Profit Margin
-67883.33%-685340.00%-1201.40%-19484.67%0.00%
Pretax Profit Margin
-67083.33%-702800.00%-1291.24%-19786.68%0.00%
Net Profit Margin
-67083.33%-702800.00%-1286.69%-19320.10%0.00%
Continuous Operations Profit Margin
-47766.67%-702800.00%-1291.24%-19786.68%0.00%
Net Income Per EBT
100.00%100.00%99.65%97.64%98.59%
EBT Per EBIT
98.82%102.55%107.48%101.55%99.52%
Return on Assets (ROA)
-108.08%-425.27%-57.90%-81.06%-53.88%
Return on Equity (ROE)
-167.97%-557.16%-97.52%-132.45%-63.60%
Return on Capital Employed (ROCE)
-145.31%-543.32%-86.10%-98.38%-62.79%
Return on Invested Capital (ROIC)
-145.31%-543.32%-59.64%-85.90%-61.13%
Return on Tangible Assets
-108.08%-425.27%-57.90%-81.06%-53.88%
Earnings Yield
-0.05%-207.06%-26.67%-32.90%-14.93%
Efficiency Ratios
Receivables Turnover
0.00 5.00 730.50 0.36 0.00
Payables Turnover
0.22 7.80 1.99 0.54 1.18
Inventory Turnover
0.00 0.00 0.20 0.00 0.00
Fixed Asset Turnover
0.06 2.50 0.28 0.03 0.00
Asset Turnover
<0.01 <0.01 0.04 <0.01 0.00
Working Capital Turnover Ratio
<0.01 <0.01 0.06 <0.01 0.00
Cash Conversion Cycle
-1.66K 26.19 1.66K 344.13 -310.64
Days of Sales Outstanding
0.00 73.00 0.50 1.02K 0.00
Days of Inventory Outstanding
0.00 0.00 1.84K 0.00 0.00
Days of Payables Outstanding
1.66K 46.81 183.76 674.76 310.64
Operating Cycle
0.00 73.00 1.84K 1.02K 0.00
Cash Flow Ratios
Operating Cash Flow Per Share
>-0.01 -18.84 -20.19 -43.00 -40.79
Free Cash Flow Per Share
>-0.01 -18.97 -20.34 -45.33 -47.79
CapEx Per Share
<0.01 0.12 0.15 2.32 7.00
Free Cash Flow to Operating Cash Flow
1.03 1.01 1.01 1.05 1.17
Dividend Paid and CapEx Coverage Ratio
-1.24 -153.01 -135.33 -18.50 -5.83
Capital Expenditure Coverage Ratio
-1.24 -153.01 -135.33 -18.50 -5.83
Operating Cash Flow Coverage Ratio
0.00 0.00 -1.50 -2.09 -11.84
Operating Cash Flow to Sales Ratio
-484.83 -6.03K -10.00 -154.44 0.00
Free Cash Flow Yield
-39.04%-178.77%-20.89%-27.72%-12.64%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-1.87K -0.48 -3.75 -3.04 -6.70
Price-to-Sales (P/S) Ratio
1.28K 3.39K 48.24 587.17 0.00
Price-to-Book (P/B) Ratio
2.69K 2.69 3.66 4.03 4.26
Price-to-Free Cash Flow (P/FCF) Ratio
-2.56 -0.56 -4.79 -3.61 -7.91
Price-to-Operating Cash Flow Ratio
-2.59K -0.56 -4.82 -3.80 -9.27
Price-to-Earnings Growth (PEG) Ratio
-306.87 0.03 0.07 0.65 0.10
Price-to-Fair Value
2.69K 2.69 3.66 4.03 4.26
Enterprise Value Multiple
-1.43 -0.35 -3.82 -2.49 -5.30
Enterprise Value
5.76M 10.91M 121.40M 187.01M 418.03M
EV to EBITDA
-1.43 -0.35 -3.82 -2.49 -5.30
EV to Sales
960.30 2.18K 41.55 469.86 0.00
EV to Free Cash Flow
-1.92 -0.36 -4.12 -2.89 -6.26
EV to Operating Cash Flow
-1.98 -0.36 -4.15 -3.04 -7.33
Tangible Book Value Per Share
<0.01 3.94 26.63 40.62 88.71
Shareholders’ Equity Per Share
<0.01 3.94 26.63 40.62 88.71
Tax and Other Ratios
Effective Tax Rate
0.00 0.00 <0.01 0.02 0.01
Revenue Per Share
<0.01 <0.01 2.02 0.28 0.00
Net Income Per Share
>-0.01 -21.97 -25.97 -53.80 -56.42
Tax Burden
1.00 1.00 1.00 0.98 0.99
Interest Burden
1.41 1.06 1.09 1.02 1.00
Research & Development to Revenue
152.50 3.26K 8.56 124.73 0.00
SG&A to Revenue
527.33 2.44K 4.50 69.26 0.00
Stock-Based Compensation to Revenue
76.67 560.00 1.21 27.07 0.00
Income Quality
0.72 0.86 0.77 0.78 0.71
Currency in USD